arabinofuranosylcytosine triphosphate has been researched along with Leukemia L 1210 in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (80.00) | 18.7374 |
1990's | 4 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cadman, E; Rauscher, F | 1 |
Cadman, E; Grant, S | 1 |
Campbell, J; Mayhew, E; Rustum, YM; Szoka, F | 1 |
Cadman, E; Grant, S; Lehman, C | 1 |
Grindey, GB; Kinahan, JJ; Kowal, EP | 1 |
Kawai, Y; Nakamura, T; Ueda, T | 1 |
Malmberg, M; Minderman, H; Raymakers, RA; Rustum, YM; Slocum, HK | 1 |
Iwasaki, H; Kamiya, K; Kawai, Y; Nakamura, T; Takauji, R; Tohyama, K; Ueda, T; Yamauchi, T | 1 |
Dave, C; Mayhew, E; Papahadjopoulos, D; Rustum, YM | 1 |
Cadman, E; Eiferman, F | 1 |
Arai, Y; Inoue, I; Kondo, K; Nagura, T | 1 |
Hilliard, S; Peck, C; Roberts, D; Wingo, W | 1 |
Balázová, E; Benesová, M; Novotný, L; Reichelová, V; Scheithauer, W; Ujházy, V | 1 |
Riva, CM; Rustum, YM | 1 |
Campbell, J; Mayhew, E; Radel, S; Rustum, YM | 1 |
Preisler, HD; Riva, C; Rustum, YM | 1 |
Grindey, GB; Plunkett, W | 1 |
Preisler, HD; Riva, CM; Rustum, YM | 1 |
Kufe, DW; Spriggs, DR | 1 |
Hirota, H; Kamiya, H; Kawasaki, H; Komada, M; Nobori, T; Okubo, T; Sako, T; Sakurai, M; Shimizu, N | 1 |
1 review(s) available for arabinofuranosylcytosine triphosphate and Leukemia L 1210
Article | Year |
---|---|
Biochemical and cellular pharmacology of cytosine arabinoside.
Topics: Animals; Aphidicolin; Arabinofuranosylcytosine Triphosphate; Binding, Competitive; Cell Line; Cell Survival; Centrifugation, Density Gradient; Cytarabine; Diterpenes; DNA; DNA Repair; DNA Replication; Fibroblasts; Granulocytes; Humans; Kinetics; Leukemia L1210; Leukemia, Myeloid, Acute; Nucleic Acid Synthesis Inhibitors; Templates, Genetic; Vidarabine | 1985 |
19 other study(ies) available for arabinofuranosylcytosine triphosphate and Leukemia L 1210
Article | Year |
---|---|
Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cell Line; Cell Survival; Cytarabine; Cytidine Triphosphate; DNA; Humans; Hydroxyurea; Kinetics; Leukemia L1210; Leukemia, Myeloid; Mice; RNA | 1983 |
Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cell Line; Cell Survival; Clone Cells; Cytarabine; Deoxyribonucleotides; Deoxyuridine; Drug Interactions; Floxuridine; Fluorodeoxyuridylate; Fluorouracil; Leukemia L1210; Mice; Uridine | 1982 |
Inability of liposome encapsulated 1-beta-D-arabinofuranosylcytosine nucleotides to overcome drug resistance in L1210 cells.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cells, Cultured; Cytarabine; Cytidine Monophosphate; DNA, Neoplasm; Drug Resistance; Female; Leukemia L1210; Liposomes; Mice; Mice, Inbred DBA | 1981 |
Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cytarabine; Deoxycytidine; Deoxyribonucleotides; DNA, Neoplasm; Leukemia L1210; Mice; RNA, Neoplasm; Thymidine; Time Factors | 1980 |
Biochemical and antitumor effects of the combination of thymidine and 1-beta-D-arabinofuranosylcytosine against leukemia L1210.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Aspartic Acid; Cells, Cultured; Cytarabine; Cytidine; Drug Therapy, Combination; Leukemia L1210; Mice; Phosphonoacetic Acid; Thymidine | 1981 |
Modulation of the effect of 1-beta-D-arabinofuranosylcytosine by 6-mercaptopurine in L1210 cells.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Biological Transport; Cytarabine; Cytidine Deaminase; DNA, Neoplasm; Drug Synergism; In Vitro Techniques; Leukemia L1210; Mercaptopurine; Mice; Tumor Cells, Cultured | 1994 |
Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cell Division; Cytarabine; Image Processing, Computer-Assisted; Kinetics; Leukemia L1210; Mice; Tumor Cells, Cultured | 1993 |
Intracellular pharmacodynamics of ara-C and flowcytometric analysis of cell cycle progression in leukemia chemotherapy.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Arabinofuranosylcytosine Triphosphate; Biotransformation; Cell Cycle; Cell Survival; Cytarabine; Daunorubicin; DNA, Neoplasm; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; HL-60 Cells; Humans; Kinetics; Leukemia L1210; Mercaptopurine; Mice; Tumor Cells, Cultured | 1997 |
Use of liposomes for the enhancement of the cytotoxic effects of cytosine arabinoside.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cytarabine; Drug Synergism; Female; Leukemia L1210; Liposomes; Mice; Mice, Inbred DBA; Pharmaceutical Vehicles; Phosphatidylcholines; Phosphatidylserines; Pregnancy; Tissue Distribution | 1978 |
Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cell Survival; Cells, Cultured; Cytarabine; Deoxyribonucleotides; Drug Synergism; Humans; In Vitro Techniques; Leukemia L1210; Leukemia, Myeloid, Acute; Methotrexate; Mice | 1979 |
Studies on biologically active nucleosides and nucleotides. 5. Synthesis and antitumor activity of some 2,2'-anhydro-1-(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine salts and 2,2'-anhydro-1-(3'-O-acyl-beta-D-arabinofuranoxyl)cytosine 5'-phosphates.
Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Female; Leukemia L1210; Methods; Mice; Structure-Activity Relationship | 1979 |
Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Arabinonucleotides; Cytarabine; Deoxycytidine Kinase; Drug Therapy, Combination; Female; Leukemia L1210; Methotrexate; Mice; Mice, Inbred Strains; Time Factors | 1979 |
Biotransformation and in vitro activity of an arabinosylcytosine 5'-chloro-5'-deoxy analog.
Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Biotransformation; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Culture Media; Cytarabine; DNA, Neoplasm; Hydrogen-Ion Concentration; Leukemia L1210; Phosphorylation; Pyrimidine Nucleosides; Temperature; Tumor Cells, Cultured | 1991 |
1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Bone Marrow; Deoxycytidine Kinase; DNA, Neoplasm; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lymphoma; Mice; Neoplasm Transplantation; Nucleoside-Phosphate Kinase; Phosphotransferases; Thymidine | 1985 |
Approaches to overcome in vivo anti-cancer drug resistance.
Topics: 3-Deazauridine; Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Cell Line; Cytarabine; Doxorubicin; Drug Resistance; Drug Synergism; Fluorouracil; Leucovorin; Leukemia L1210; Liposomes; Mice; Verapamil | 1986 |
Pharmacokinetic parameters of 1-beta-D-arabinofuranosylcytosine (ara-C) and their relationship to intracellular metabolism of ara-C, toxicity, and response of patients with acute nonlymphocytic leukemia treated with conventional and high-dose ara-C.
Topics: Acute Disease; Animals; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; Drug Administration Schedule; Humans; Leukemia; Leukemia L1210; Metabolic Clearance Rate; Mice; Uridine Kinase | 1987 |
Pharmacokinetics of the 5'-triphosphates of arabinosylcytosine and 2',2'-difluorodeoxycytidine in L1210 cells.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Biological Transport; Cytarabine; Cytidine Triphosphate; Cytosine Nucleotides; Leukemia L1210; Mice; Structure-Activity Relationship | 1987 |
Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Bone Marrow; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance; Humans; Leukemia; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice; Mice, Inbred DBA | 1985 |
Enhanced production of intracellular ara-CTP after sequential use of methotrexate and 1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Deoxycytosine Nucleotides; Drug Administration Schedule; Leukemia L1210; Male; Methotrexate; Mice; Mice, Inbred Strains | 1985 |